Family

+

−

• No Family data available.

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
YE CHUN	NO 24 LANE 8 GONGYUAN SOUTH ROAD LIANZHOU TOWN HEPU COUNTY BEIHAI CITY GUANGXI ZHUANG AUTONOMOUS REGION 536100 BEIHAI CITY THE GUANGXI ZHUANG AUTONOMOUS REGION 536100

International Classification(s)

• H02J:CIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR D....

• 2024 Application Filing Year
• H02J Class
• 2544 Applications Filed
• 167 Patents Issued To-Date
• 6.57 % Issued To-Date

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Ye, Chun	Shenzhen, CN	20	201
# of filed Patents : 20 Total Citations : 201

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

• 0 Citation Count
• H02J Class

• 0 % this patent is cited more than
• 1 Age

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
3.5 Year Payment	$1600.00	$800.00	$400.00	Dec 27, 2027
7.5 Year Payment	$3600.00	$1800.00	$900.00	Dec 27, 2031
11.5 Year Payment	$7400.00	$3700.00	$1850.00	Dec 27, 2035

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 3.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge - 7.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

Full Text

US Patent Application No: 11453684

Method of treating a proliferative disorder by administering a thiourea gold(I) complex

---

Abstract

---

The invention is directed to a method of treatment of proliferative diseases or disorders such as cancer with gold(I) N-heterocyclic carbene (NHC) thiourea or substituted thiourea complexes, to the complexes per se and to therapeutic compositions containing these gold(I) based complexes.

---

 

---

Description

---

Claims

---

Claims data not available

---

Legal Events

 

• P2022
• STCF2022
• STPP2022
• STPP2022
• STCB2021
• STPP2020
• P2020
• FEPP2020
• F2020
• FEPP2020

Date	Code	Event	Description
Sep 27, 2022	P	Publication
Sep 07, 2022	STCF	INFORMATION ON STATUS: PATENT GRANT	free format text: PATENTED CASE
Aug 10, 2022	STPP	INFORMATION ON STATUS: PATENT APPLICATION AND GRANTING PROCEDURE IN GENERAL	free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS
Aug 02, 2022	STPP	INFORMATION ON STATUS: PATENT APPLICATION AND GRANTING PROCEDURE IN GENERAL	free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER
May 11, 2021	STCB	INFORMATION ON STATUS: APPLICATION DISCONTINUATION	free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION
Oct 15, 2020	STPP	INFORMATION ON STATUS: PATENT APPLICATION AND GRANTING PROCEDURE IN GENERAL	free format text: NON FINAL ACTION MAILED
Sep 24, 2020	P	Published
Feb 12, 2020	FEPP	FEE PAYMENT PROCEDURE	free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY
Jan 27, 2020	F	Filing
Jan 27, 2020	FEPP	FEE PAYMENT PROCEDURE	free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY